Details of the Drug

General Information of Drug (ID: DMPXOVA)

Drug Name
IN10018
Indication
Disease Entry ICD 11 Status REF
Metastatic melanoma 2E2Z Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
46207957
TTD ID
D1EW3O

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Focal adhesion kinase 1 (FAK) TTON5IT FAK1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04109456) IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of InxMed.